ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Income Before Tax Over TimeContracting
Percentile Rank60
3Y CAGR-26.8%
Studio
Year-over-Year Change

Pre-tax earnings

3Y CAGR
-26.8%/yr
vs -5.5%/yr prior
Acceleration
-21.2pp
Decelerating
Percentile
P60
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$216.84M-78.2%
2025$994.63M+11.7%
2024$890.47M+61.2%
2023$552.47M+197.1%
2022$-568.99M+40.3%
2021$-952.49M-36.7%
2020$-696.92M-200.4%
2019$694.08M+117.4%
2018$-3.99B+26.6%
2017$-5.44B-